8 Recruiting Studies Using Lorlatinib
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Lorlatinib
🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer
📍 Memorial Sloan Kettering Monmouth (All Protocol Activities) — Middletown, New Jersey
Non Small Cell Lung Cancer
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC
📍 Florida Cancer Specialists — Altamonte Springs, Florida
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase4 💊 Investigational Drug / Biologic
Lorlatinib Continuation Study
📍 Chao Family Comprehensive Cancer Center and Ambulatory Care — Irvine, California
Non-Small-Cell Lung Cancer
View Study & Checklist ➔ 🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research
A Study to Learn About Patients With Non-Small Cell Lung Cancer (NSCLC) Who Took Lorlatinib as Their First Treatment
📍 Pfizer — New York, New York
Non-Small-Cell Lung
View Study & Checklist ➔ 🟢 Recruiting Early Phase1 💊 Investigational Drug / Biologic
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
📍 Children's Hospital Colorado — Aurora, Colorado
High Grade Glioma
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
📍 Children's Hospital of Alabama — Birmingham, Alabama
Ganglioneuroblastoma
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Study of NXP900 With Lorlatinib in ALK+ Lung Cancer
📍 NEXT Virginia — Fairfax, Virginia
ALK Positive
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Lorlatinib Plus Local Consolidation Therapy In ALK Positive Advanced Non-Small Cell Lung Cancer
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
Advanced Non-Small Cell Lung Cancer
View Study & Checklist ➔